volume 59, issue 4, P939-943 2001
DOI: 10.1590/s0004-282x2001000600019
View full text
|
|
Share

Abstract: ABSTRACT -Intracranial meningiomas continue to challenge our best clinical efforts to eliminate them once discovered and deemed appropriate for treatment. Malignant meningiomas constitute 10% to 15% of all meningiomas and limited information exists regarding adjuvant treatment. The external whole brain irradiation is recommended. Traditional chemotherapy has proven ineffective; thus, new chemotherapeutic agents and new methods of delivery should be developed. Immunotherapy may be considered for patients with …

Expand abstract